中成药临床合理用药处方点评北京共识

2018-03-20 中医相关专家组(统称) 中国中医药杂志.2018.43(5):1049-1053.

随着中成药品规数和临床使用的增长,中成药临床合理使用问题日趋严峻。由于中成药本身的复杂性和临床应用的不确定性影响,中成药处方点评长期缺乏行业技术规范,导致其临床合理使用缺乏科学的风险管控措施。遵循中医药基本理论及独特的临床治疗学特点,结合中成药临床实践经验和专家意见,形成北京市中成药临床合理用药处方点评专家共识,包括中成药处方点评基本方法、技术以及主要点评要点,以期为规范中成药临床合理用药处方点评

中文标题:

中成药临床合理用药处方点评北京共识

发布日期:

2018-03-20

简要介绍:

随着中成药品规数和临床使用的增长,中成药临床合理使用问题日趋严峻。由于中成药本身的复杂性和临床应用的不确定性影响,中成药处方点评长期缺乏行业技术规范,导致其临床合理使用缺乏科学的风险管控措施。遵循中医药基本理论及独特的临床治疗学特点,结合中成药临床实践经验和专家意见,形成北京市中成药临床合理用药处方点评专家共识,包括中成药处方点评基本方法、技术以及主要点评要点,以期为规范中成药临床合理用药处方点评行为,提升中成药临床合理用药水平提供技术参考。

 

拓展指南:中成药相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=中成药临床合理用药处方点评北京共识)] GetToolGuiderByIdResponse(projectId=1, id=d20dc1c0015e5ae2, title=中成药临床合理用药处方点评北京共识, enTitle=, guiderFrom=中国中医药杂志.2018.43(5):1049-1053., authorId=null, author=, summary=随着中成药品规数和临床使用的增长,中成药临床合理使用问题日趋严峻。由于中成药本身的复杂性和临床应用的不确定性影响,中成药处方点评长期缺乏行业技术规范,导致其临床合理使用缺乏科学的风险管控措施。遵循中医药基本理论及独特的临床治疗学特点,结合中成药临床实践经验和专家意见,形成北京市中成药临床合理用药处方点评专家共识,包括中成药处方点评基本方法、技术以及主要点评要点,以期为规范中成药临床合理用药处方点评, cover=, journalId=null, articlesId=null, associationId=1108, associationName=中医相关专家组(统称), associationIntro=null, copyright=0, guiderPublishedTime=Tue Mar 20 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<P>随着中成药品规数和临床使用的增长,中成药临床合理使用问题日趋严峻。由于中成药本身的复杂性和临床应用的不确定性影响,中成药处方点评长期缺乏行业技术规范,导致其临床合理使用缺乏科学的风险管控措施。遵循中医药基本理论及独特的临床治疗学特点,结合中成药临床实践经验和专家意见,形成北京市中成药临床合理用药处方点评专家共识,包括中成药处方点评基本方法、技术以及主要点评要点,以期为规范中成药临床合理用药处方点评行为,提升中成药临床合理用药水平提供技术参考。 </P> <P> </P>拓展指南:<strong>与<font color=red>中成药</font>相关指南:</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=6baee1c001258002" title="2016 中成药治疗寻常痤疮专家共识" target=_blank>2016 中成药治疗寻常痤疮专家共识</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=3566b1c0010852ac" title="外用中成药治疗湿疹皮炎的专家共识(2014)" target=_blank>外用中成药治疗湿疹皮炎的专家共识(2014)</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=bce1d1c0010620a7" title="中成药治疗寻常性银屑病专家共识(2014)" target=_blank>中成药治疗寻常性银屑病专家共识(2014)</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=9f9e01c0009ae878" title="2012 外用中成药治疗湿疹皮炎的专家共识" target=_blank>2012 外用中成药治疗湿疹皮炎的专家共识</a></li> 更多信息请点击:<a href="http://www.medsci.cn/guideline/list.do?q=%E4%B8%AD%E6%88%90%E8%8D%AF" target=_blank>有关中成药更多指南</a></ul>, tagList=[TagDto(tagId=7570, tagName=中成药), TagDto(tagId=72646, tagName=临床合理用药), TagDto(tagId=51996, tagName=处方点评)], categoryList=[CategoryDto(categoryId=37, categoryName=中医科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=13606, appHits=152, showAppHits=4, pcHits=6236, showPcHits=8385, likes=127, shares=10, comments=4, approvalStatus=1, publishedTime=Tue Apr 03 22:05:31 CST 2018, publishedTimeString=2018-03-20, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Tue Apr 03 22:05:31 CST 2018, updatedBy=null, updatedName=null, updatedTime=Fri Jan 05 13:46:01 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=中成药临床合理用药处方点评北京共识)])
中成药临床合理用药处方点评北京共识
下载请点击:
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=894740, encodeId=3531894e408e, content=给力阿, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201120/5c0c541ffceb4f11b0948c3e262b6e70/5b6894da824e43cca0ba37dddeca4910.jpg, createdBy=f45a2515633, createdName=124cb330m11暂无昵称, createdTime=Tue Oct 27 10:36:06 CST 2020, time=2020-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=302631, encodeId=6b2c30263186, content=红红火火恍恍惚惚哈哈哈哈, beContent=null, objectType=guider, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/07/8c1e5a0085f3b74f3a4ab58a38a3d487.jpg, createdBy=b33e2159612, createdName=2227437833_79976374, createdTime=Wed Apr 04 08:45:33 CST 2018, time=2018-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=302474, encodeId=11463024e490, content=不错的文章值得拥有, beContent=null, objectType=guider, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Tue Apr 03 23:15:12 CST 2018, time=2018-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=302459, encodeId=44a230245962, content=^_^^_^^_^, beContent=null, objectType=guider, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Swp2ehfHpiciczeTntUyQOlIGMzQ705ic67sdMTVMbwTv7KbmlUvxrGvRSvQZjPkz7ib5tEDfIaORgczPtmHDpwojg/0, createdBy=c54b2163125, createdName=wqkm, createdTime=Tue Apr 03 22:21:38 CST 2018, time=2018-04-03, status=1, ipAttribution=)]
    2020-10-27 124cb330m11暂无昵称

    给力阿

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=894740, encodeId=3531894e408e, content=给力阿, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201120/5c0c541ffceb4f11b0948c3e262b6e70/5b6894da824e43cca0ba37dddeca4910.jpg, createdBy=f45a2515633, createdName=124cb330m11暂无昵称, createdTime=Tue Oct 27 10:36:06 CST 2020, time=2020-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=302631, encodeId=6b2c30263186, content=红红火火恍恍惚惚哈哈哈哈, beContent=null, objectType=guider, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/07/8c1e5a0085f3b74f3a4ab58a38a3d487.jpg, createdBy=b33e2159612, createdName=2227437833_79976374, createdTime=Wed Apr 04 08:45:33 CST 2018, time=2018-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=302474, encodeId=11463024e490, content=不错的文章值得拥有, beContent=null, objectType=guider, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Tue Apr 03 23:15:12 CST 2018, time=2018-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=302459, encodeId=44a230245962, content=^_^^_^^_^, beContent=null, objectType=guider, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Swp2ehfHpiciczeTntUyQOlIGMzQ705ic67sdMTVMbwTv7KbmlUvxrGvRSvQZjPkz7ib5tEDfIaORgczPtmHDpwojg/0, createdBy=c54b2163125, createdName=wqkm, createdTime=Tue Apr 03 22:21:38 CST 2018, time=2018-04-03, status=1, ipAttribution=)]
    2018-04-04 2227437833_79976374

    红红火火恍恍惚惚哈哈哈哈

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=894740, encodeId=3531894e408e, content=给力阿, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201120/5c0c541ffceb4f11b0948c3e262b6e70/5b6894da824e43cca0ba37dddeca4910.jpg, createdBy=f45a2515633, createdName=124cb330m11暂无昵称, createdTime=Tue Oct 27 10:36:06 CST 2020, time=2020-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=302631, encodeId=6b2c30263186, content=红红火火恍恍惚惚哈哈哈哈, beContent=null, objectType=guider, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/07/8c1e5a0085f3b74f3a4ab58a38a3d487.jpg, createdBy=b33e2159612, createdName=2227437833_79976374, createdTime=Wed Apr 04 08:45:33 CST 2018, time=2018-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=302474, encodeId=11463024e490, content=不错的文章值得拥有, beContent=null, objectType=guider, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Tue Apr 03 23:15:12 CST 2018, time=2018-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=302459, encodeId=44a230245962, content=^_^^_^^_^, beContent=null, objectType=guider, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Swp2ehfHpiciczeTntUyQOlIGMzQ705ic67sdMTVMbwTv7KbmlUvxrGvRSvQZjPkz7ib5tEDfIaORgczPtmHDpwojg/0, createdBy=c54b2163125, createdName=wqkm, createdTime=Tue Apr 03 22:21:38 CST 2018, time=2018-04-03, status=1, ipAttribution=)]
    2018-04-03 1e1b8538m79(暂无匿称)

    不错的文章值得拥有

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=894740, encodeId=3531894e408e, content=给力阿, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201120/5c0c541ffceb4f11b0948c3e262b6e70/5b6894da824e43cca0ba37dddeca4910.jpg, createdBy=f45a2515633, createdName=124cb330m11暂无昵称, createdTime=Tue Oct 27 10:36:06 CST 2020, time=2020-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=302631, encodeId=6b2c30263186, content=红红火火恍恍惚惚哈哈哈哈, beContent=null, objectType=guider, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/07/8c1e5a0085f3b74f3a4ab58a38a3d487.jpg, createdBy=b33e2159612, createdName=2227437833_79976374, createdTime=Wed Apr 04 08:45:33 CST 2018, time=2018-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=302474, encodeId=11463024e490, content=不错的文章值得拥有, beContent=null, objectType=guider, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Tue Apr 03 23:15:12 CST 2018, time=2018-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=302459, encodeId=44a230245962, content=^_^^_^^_^, beContent=null, objectType=guider, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Swp2ehfHpiciczeTntUyQOlIGMzQ705ic67sdMTVMbwTv7KbmlUvxrGvRSvQZjPkz7ib5tEDfIaORgczPtmHDpwojg/0, createdBy=c54b2163125, createdName=wqkm, createdTime=Tue Apr 03 22:21:38 CST 2018, time=2018-04-03, status=1, ipAttribution=)]
    2018-04-03 wqkm

    ^_^^_^^_^

    0